ExodusPoint Capital Management’s Avidity Biosciences RNAM Stock Holding History

ExodusPoint Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-148,731	Closed	-$10.7M	–	2018
2025 Q4	$10.7M	Buy	148,731 +89,896	+153%	+$5.81M	0.08%	239
2025 Q3	$2.56M	Buy	+58,835	New	+$2.38M	0.03%	652
2025 Q1	–	Sell	-33,844	Closed	-$984K	–	1925
2024 Q4	$984K	Buy	+33,844	New	+$1.41M	0.01%	954
2023 Q4	–	Sell	-105,062	Closed	-$670K	–	1963
2023 Q3	$670K	Buy	+105,062	New	+$905K	0.01%	1133

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

ExodusPoint Capital Management's RNAM Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 148,731 shares — an estimated $10.7M sold.

ExodusPoint Capital Management first reported a position in RNAM in Q3 2023 and held it in 4 quarters. The position peaked at $10.7M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

ExodusPoint Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
ExodusPoint Capital Management sold 148,731 Avidity Biosciences shares in Q1 2026, an estimated $10.7M.
ExodusPoint Capital Management first reported a position in Avidity Biosciences in Q3 2023 and held it in 4 quarters.
ExodusPoint Capital Management's Avidity Biosciences position peaked at $10.7M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.